BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 4994941)

  • 1. [Anatomic and bacteriologic testing of rifampicin effectiveness in treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(3):434-8. PubMed ID: 4994941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ
    Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
    Homenko AG; Ciukanov VL
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 12. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cooperative study of short-term antibacillary treatments in 14 French centers].
    Brouet G
    Bull Int Union Tuberc; 1974; 49(1):398-410. PubMed ID: 4219734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacterial isolation during chemotherapy of patients with pulmonary tuberculosis].
    Afanas'eva IuP; Kuznetsova VI
    Probl Tuberk; 1977 Dec; (12):32-6. PubMed ID: 416433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
    Dormer BA; Salinger PL
    S Afr Med J; 1971 Jun; 45(25):697-9. PubMed ID: 5559403
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
    Wipf R
    Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.